FDA Approves Two New Antibiotics, Zoliflodacin and Gepotidacin, to Treat Drug-Resistant Gonorrhea
MONDAY, Dec. 15, 2025 Doctors now have new tools to fight gonorrhea, a common sexually transmitted infection that has grown harder to treat over time. The U.S.